Boone Capital Management LLC Decreases Stock Holdings in Cigna Group $CI

13 Dec 2025, 04:58 by Teresa Graham · The Cerbat Gem

Boone Capital Management LLC cut its position in Cigna Group (NYSE:CI – Free Report) by 49.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 35,600 shares of the health services provider’s stock after selling 35,259 shares during the quarter. Cigna Group comprises 5.0% of Boone Capital Management LLC’s portfolio, making the stock its 10th biggest holding. Boone Capital Management LLC’s holdings in Cigna Group were worth $11,769,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Flaharty Asset Management LLC bought a new position in Cigna Group in the first quarter valued at approximately $28,000. 1248 Management LLC bought a new position in shares of Cigna Group in the 1st quarter valued at $29,000. Solstein Capital LLC acquired a new position in shares of Cigna Group during the 2nd quarter worth $29,000. Activest Wealth Management raised its holdings in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after buying an additional 72 shares in the last quarter. Finally, Chilton Capital Management LLC bought a new stake in shares of Cigna Group during the 2nd quarter worth $30,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Performance

Cigna Group stock opened at $274.70 on Friday. The business has a 50 day moving average of $280.44 and a 200-day moving average of $294.17. The company has a market capitalization of $73.38 billion, a P/E ratio of 12.12, a P/E/G ratio of 0.99 and a beta of 0.26. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.76 and a quick ratio of 0.76.

Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The firm had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same period in the previous year, the firm posted $7.51 EPS. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is currently 26.64%.

Insider Activity

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David Cordani purchased 4,134 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the purchase, the chief executive officer owned 157,935 shares of the company’s stock, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CI shares. Morgan Stanley reiterated an “overweight” rating and issued a $355.00 target price on shares of Cigna Group in a research report on Friday, October 31st. Sanford C. Bernstein reduced their price target on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a research note on Wednesday, November 12th. Guggenheim reaffirmed a “buy” rating and set a $318.00 price target on shares of Cigna Group in a report on Tuesday, December 2nd. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating on the stock in a research report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $331.77.

Get Our Latest Report on CI

Cigna Group Company Profile

(Free Report)